Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review
Frontiers in Microbiology · 30.07.2024 · 15
DOI: 10.3389/fmicb.2024.1420226 ↗Kurz gefasst
Scoping Review in der Zeitschrift Frontiers in Microbiology, online erschienen am 30.07.2024. Verfasst von Carlos Ananias Aparecido Resende und 18 weiteren Autor:innen. Beteiligte Einrichtung: Microorganism Biotechnology Laboratory, National Institute of Science and Technology on Industrial Biotechnology (INCT-BI), Federal University of São…. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Chagas disease (CD), caused by the protozoan Trypanosoma cruzi , is an important public health problem, occurring mainly in Latin America. The disease has a major social and economical effect, negatively impacting the life of the infected individuals, and bringing great costs to public health. An early and accurate diagnosis is essential for administration of early treatment. In addition, prognostic tests may aid disease management, decreasing hospitalization costs. However, the serological diagnostic scenario for CD still faces several challenges, making the development of new diagnostic kits a pressing matter. Facing this scenario, several researchers have expanded efforts in developing and testing new antigens, such as recombinant proteins and recombinant multiepitope proteins, with promising results. These recombinant antigens offer several advantages, such as improved sensitivity and specificity, in addition to facilitated scaling. Also, it has been possible to observe a rising number of studies using ELISA and point-of-care platforms, employing these antigens in the past few years. Among them, recombinant proteins were the most applied antigens, demonstrating great capacity to discriminate between positive and negative samples. Although fewer in number, recombinant multiepitope proteins also demonstrated an improved diagnostic performance. Indeed, a great number of studies employing these antigens showed sensitivity and specificity values above 90%, greatly impacting diagnostic accuracy. Nevertheless, despite the good results found, it is still possible to observe some bottlenecks in the development of new antigens, such as the scarcity of tests with sera from the acute phase and the variability of results in different geographic areas. In this sense, aiming to contribute to control and health programs, the continuous search for a more accurate serological diagnosis is essential, both for the acute and chronic phases of the disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Microorganism Biotechnology Laboratory, National Institute of Science and Technology on Industrial Biotechnology (INCT-BI), Federal University of São João Del-Rei, Divinópolis, Brazil.
- Laboratory of Bioactives and Nanobiotechnology, Federal University of São João Del-Rei, Divinópolis, Brazil.
- Postgraduate Program in Health Sciences, Infectious Diseases and Tropical Medicine, Faculty of Medicine, Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Laboratory of Biology of Cell Interactions, Department of Morphology, National Institute of Science and Technology on Tropical Diseases (INCT-T), Federal University of Minas Gerais, Belo Horizonte, Brazil.
- Computational Biology and Chemistry Research Group, Vicerrectorado de Investigación, Universidad Católica de Santa María, Arequipa, Peru.
Zitieren
APA
Resende, C. A. A., Ribeiro, A. J., Gandra, I. B., Silva, K. A., Lopes, L. D. S., Barcelos, I. C. D. S., Couto, C. A. P., de Faria, M. T., Pereira, S. P., Xavier, S. R., Machado, J. M., da Paz, M. C., Chaves, A. T., Coelho, E. A. F., Giunchetti, R. C., Chávez-Fumagalli, M. A., Dutra, W. O., Gonçalves, A. A. M., & Galdino, A. S. (2024). Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review. Frontiers in Microbiology, 15. https://doi.org/10.3389/fmicb.2024.1420226
Vancouver
Resende CAA, Ribeiro AJ, Gandra IB, Silva KA, Lopes LDS, Barcelos ICDS, et al. Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review. Frontiers in Microbiology. 2024;15. doi:10.3389/fmicb.2024.1420226
BibTeX
@article{Resende2024,
author = {Resende, Carlos Ananias Aparecido and Ribeiro, Anna Júlia and Gandra, Isadora Braga and Silva, Kamila Alves and Lopes, Lucas da Silva and Barcelos, Isabelle Caroline Dos Santos and Couto, Carolina Alves Petit and de Faria, Mariana Teixeira and Pereira, Sabrina Paula and Xavier, Sandra Rodrigues and Machado, Juliana Martins and da Paz, Mariana Campos and Chaves, Ana Thereza and Coelho, Eduardo Antônio Ferraz and Giunchetti, Rodolfo Cordeiro and Chávez-Fumagalli, Miguel Angel and Dutra, Walderez Ornelas and Gonçalves, Ana Alice Maia and Galdino, Alexsandro Sobreira},
title = {Recombinant proteins as promising antigens applied to the immunodiagnosis of Chagas disease: a scoping review},
journal = {Frontiers in Microbiology},
year = {2024},
volume = {15},
doi = {10.3389/fmicb.2024.1420226}
}
EUVIMED